[1] LIU X,WANG H,TAO GL,et al.LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1[J].Eur Rev Med Pharmacol Sci,2020,24(21):11006-11015.
[2] ZHENG S,JIANG F,GE D,et al.LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma[J].Biomed Pharmacother,2019,112(1):108695-108705.
[3] FU D,LU C,QU X,et al.LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis[J].Aging(Albany NY),2019,11(19):8374-8385.
[4] CHEN L,WANG J,LI JW,et al.LncRNA MEG3 inhibits proliferation and promotes apoptosis of osteosarcoma cells through regulating Notch signaling pathway[J].Eur Rev Med Pharmacol Sci,2020,24(2):581-590.
[5] ZHENG W,TIAN X,CAI L,et al.LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer[J].Eur Rev Med Pharmacol Sci,2019,23(23):10443-10452.
[6] XUE Y,LIU H,NIE G,et al.LncRNA DARS-AS1 promoted osteosarcoma progression through regulating miR-532-3p/CCR7[J].Dis Markers,2022,2022:4660217.
[7] WU X,CHEN B,SHI H,et al.miR-758-3p suppresses human bladder cancer cell proliferation,migration and invasion by targeting NOTCH2[J].Exp Ther Med,2019,17(5):273-278.
[8] ZHANG GD,LI Y,LIAO GJ,et al.LncRNA NKILA inhibits invasion and migration of osteosarcoma cells via NF-kappaB/Snail signaling pathway[J].Eur Rev Med Pharmacol Sci,2019,23(10):4118-4125.
[9] SHEN Y,XU J,PAN X,et al.LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis[J].Cell Death Dis,2020,11(4):278.
[10] HUANG YF,LU L,SHEN HL,et al.LncRNA SNHG4 promotes osteosarcoma proliferation and migration by sponging miR-377-3p[J].Mol Genet Genomic Med,2020,8(8):e1349-e1359.
[11] HUANG K,FAN WS,FU XY,et al.Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer[J].Eur Rev Med Pharmacol Sci,2020,24(13):7211-7221.
[12] JIAO M,GUO H,CHEN Y,et al.DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS[J].Biomed Pharmacother,2020,128(1):110323-110333.
[13] CHEN Y,WU Q,LIN J,et al.DARS-AS1 accelerates the proliferation of cervical cancer cells via miR-628-5p/JAG1 axis to activate Notch pathway[J].Cancer Cell Int,2020,20(1):535-545.
[14] JIANG M,LU W,DING X,et al.p16INK4a inhibits the proliferation of osteosarcoma cells through regulating the miR-146b-5p/TRAF6 pathway[J].Biosci Rep,2019,39(2):1-12.
[15] XIONG X,ZHANG J,LI A,et al.GSK343 induces programmed cell death through the inhibition of EZH2 and FBP1 in osteosarcoma cells[J].Cancer Biol Ther,2020,21(3):213-222.
[16] YANG TJ,WANG L,ZHANG Y,et al.LncRNA UCA1 regulates cervical cancer survival and EMT occurrence by targeting miR-155[J].Eur Rev Med Pharmacol Sci,2020,24(19):9869-9879.
[17] LIN J,LIAO S,LIU Z,et al.LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis[J].Cancer Biol Ther,2021,22(3):257-266.
[18] HAN G,GUO Q,MA N,et al.LncRNA BCRT1 facilitates osteosarcoma progression via regulating miR-1303/FGF7 axis[J].Aging(Albany NY),2021,13(11):15501-15510.
[19] ZHANG Z,CHEN F,ZHAN H,et al.lncRNA CASC9 sponges miR-758-3p to promote proliferation and EMT in bladder cancer by upregulating TGF-beta2[J].Oncol Rep,2021,45(1):265-277.
[20] WU Y,LIU Y.miR-758-3p inhibits proliferation,migration,and invasion of clear cell renal cell carcinoma and predicts favorable prognosis[J].Cancer Manag Res,2020,12(2):9285-9295.
[21] JIANG D,CHO WC,LI Z,et al.MiR-758-3p suppresses proliferation,migration and invasion of hepatocellular carcinoma cells via targeting MDM2 and mTOR[J].Biomed Pharmacother,2017,96(1):535-544.